OCUMYCIN Drug Patent Profile
✉ Email this page to a colleague
When do Ocumycin patents expire, and what generic alternatives are available?
Ocumycin is a drug marketed by Pharmafair and is included in one NDA.
The generic ingredient in OCUMYCIN is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ocumycin
A generic version of OCUMYCIN was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB on January 26th, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OCUMYCIN?
- What are the global sales for OCUMYCIN?
- What is Average Wholesale Price for OCUMYCIN?
Summary for OCUMYCIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | OCUMYCIN at DailyMed |
US Patents and Regulatory Information for OCUMYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | OCUMYCIN | bacitracin zinc; polymyxin b sulfate | OINTMENT;OPHTHALMIC | 062430-001 | Apr 8, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
